Awarded
Leuprorelin acetat (1:x) 11,25 mg Retardmikrokapseln und Suspensionsmittel (gyn. Indikationen) St
- Buyer
- PBMG eG
- Winners
- APOGEPHA Arzneimittel GmbH
- Contract value
- no value published
- Bids received
- 3
- Published
- 27 Feb 2026
- Awarded
- 15 Dec 2025
- Contract start
- 1 Jul 2026
- Contract end
- 30 Jun 2027stated
- Region
- Hamburg (DE600)